ERBB2 and breast cancer: Although there was no difference in Igf‐1 mRNA levels (Fig. 4A, a), Igf‐2 mRNA was significantly higher in PIK3CA‐H1047R mammary tumors in comparison with Her‐2 tumors (Fig. 4A, b).